Pharmacologic defibrillation

Critical Care Medicine

Volumn 30, Issue 4 SUPPL., 2002, Pages

  Wann, Shue Ren ^a   Weil, Max Harry ^a   Sun, Shijie ^a   Tang, Wanchun ^a   Pellis, Tommaso ^a  

^a INSTITUTE OF CRITICAL CARE MEDICINE   (United States)

Author keywords

Cardiopulmonary resuscitation; Cariporide; Defibrillation; Sodium hydrogen exchanger; Sodium hydrogen exchanger inhibitor; Ventricular fibrillation

Indexed keywords

CALCIUM ION; CARIPORIDE; SODIUM; SODIUM PROTON EXCHANGE PROTEIN;

AMPLITUDE MODULATION; ANIMAL MODEL; ARTIFICIAL VENTILATION; BOLUS INJECTION; CALCIUM CELL LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; DEFIBRILLATION; ELECTROCARDIOGRAM; HEART ARREST; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; NONHUMAN; PRIORITY JOURNAL; RAT; RESUSCITATION; SODIUM CELL LEVEL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036217605     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200204001-00007     Document Type: Conference Paper

References (27)

1. + and cellular energy
2. The effect of calcium concentration on spontaneous ventricular defibrillation and VF threshold
3. Role of calcium and the calcium channel in the initiation and maintenance of ventricular fibrillation
4. Progressive myocardial dysfunction after cardiac resuscitation
5. Myocardial dysfunction after successful resuscitation from cardiac arrest
6. Myocardial dysfunction after resuscitation from cardiac arrest: An example of global myocardial stunning
7. Cardiovascular function and neurologic outcome after cardiac arrest in dogs: The cardiovascular post-resuscitation syndrome
8. Reversible myocardial depression in survivors of cardiac arrest
9. Prehospital ventricular defibrillation: Prognosis and follow-up course
10. Thrombolytic therapy in patients requiring cardiopulmonary resuscitation
11. The stunned myocardium: Prolonged, postischemic ventricular dysfunction
12. High-energy defibrillation increases the severity of postresuscitation myocardial dysfunction
13. Calcium-mediated damage during post-ischaemic reperfusion
14. 2+ exchange
15. Reperfusion injury and its pharmacologic modification
16. The sodium/hydrogen exchange system in cardiac cells: Its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH
17. Sodium-hydrogen exchange inhibitors improve post-ischemic recovery of function in the perfused rabbit heart
18. Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart - A protective additive to ischaemic preconditioning
19. Integration of absolute ventricular fibrillation voltage correlates with successful defibrillation
20. Improved nonthoracotomy defibrillation based on ventricular fibrillation waveform characteristics
21. Cariporide facilitates successful defibrillation and improves post-resuscitation hemodynamic function after prolonged untreated VF
22. K(ATP) channel activation reduces the severity of postresuscitation myocardial dysfunction
23. Depletion of myocardial adenosine triphosphate during prolonged untreated ventricular fibrillation: Effect on defibrillation success
24. Protective effects of amiloride on the ischemic reperfused rat heart: Relation to mitochondrial function
25. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion
26. + exchange inhibitor and its effects in cardiac ischaemia
27. Heart weight affects spontaneous defibrillation but not ventricular fibrillation threshold